Clinical Trials Browser

Phase 3 × Disease Progression × Bortezomib × Clear all

NCT01191060 2026-04-06

IFM/DFCI2009

Phase 3 Completed

Disease Progression, Neoplasms, Plasma Cell

NCT01109004 2021-12-09

BMT CTN 0702

Phase 3 Completed

758 enrolled 21 charts

Hematologic Diseases, Multiple Myeloma, Disease Progression